Tags

Phase II MIRAKLE

NTC presents positive results from Phase II Mirakle study evaluating an innovative drug for bacterial conjunctivitis

NTC presents positive results from Phase II Mirakle study evaluating an innovative drug for bacterial conjunctivitis

December 05, 2024 | 18:00
NTC, an international R&D focused pharmaceutical company headquartered in Italy , presents positive results from Phase II MIRAKLE study.

Latest News

Investors navigate unpredictable landscape in 2025

Investors navigate unpredictable landscape in 2025

Securities market rapidly transforming with M&As

Securities market rapidly transforming with M&As

Additional cross-border deals depend on stronger reforms

Additional cross-border deals depend on stronger reforms

The board’s role within merger and acquisition goals

The board’s role within merger and acquisition goals

Vietnam Investment Review under the Ministry of Planning and Investment

Editor-in-Chief: Le Trong Minh

Deputy Editors-in-Chief: Bui Duc Hai, Nguyen Van Hong and Nguyen Quoc Viet

Editorial Board Member: Dang Tuan Khanh

Managing Editor: Nguyen Chi Mai

Advertisement  | Contact us

Based on MasterCMS Ultimate Edition Ver 2.9 2022
Corporate CEO Talk Biz Link PR Newswire
Investing M&A Outbound Investment Investing in Haiphong
Your Consultant KPMG PwC RSM Vietnam D.lion Dentons LuatViet
Green Growth Energy Efficiency Rethinking Plastics BASF
Property Green Buildings Industrial Properties
Money Insurance Smart Payment Trends Stock Monitor
Infographics
Timeout Travel Hotels & Restaurants The Insider Entertainment Lifestyle
Sports
Photos
Society Swing for the Kids CSR
World News
virs-publications-vir
timeout-vn
ptbv2020